## Abstract Genome‐wide association studies employ hundreds of thousands of statistical tests to determine which regions of the genome may likely harbor disease‐causing alleles. Such large‐scale testing simultaneously requires stringent control over type I error and maintenance of sufficient power
Upward bias in odds ratio estimates from genome-wide association studies
✍ Scribed by Chad Garner
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 883 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0741-0395
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Genome‐wide association studies are carried out to identify unknown genes for a complex trait. Polymorphisms showing the most statistically significant associations are reported and followed up in subsequent confirmatory studies. In addition to the test of association, the statistical analysis provides point estimates of the relationship between the genotype and phenotype at each polymorphism, typically an odds ratio in case‐control association studies. The statistical significance of the test and the estimator of the odds ratio are completely correlated. Selecting the most extreme statistics is equivalent to selecting the most extreme odds ratios. The value of the estimator, given the value of the statistical significance depends on the standard error of the estimator and the power of the study. This report shows that when power is low, estimates of the odds ratio from a genome‐wide association study, or any large‐scale association study, will be upwardly biased. Genome‐wide association studies are often underpowered given the low α levels required to declare statistical significance and the small individual genetic effects known to characterize complex traits. Factors such as low allele frequency, inadequate sample size and weak genetic effects contribute to large standard errors in the odds ratio estimates, low power and upwardly biased odds ratios. Studies that have high power to detect an association with the true odds ratio will have little or no bias, regardless of the statistical significance threshold. The results have implications for the interpretation of genome‐wide association analysis and the planning of subsequent confirmatory stages. Genet Epidemiol. 2007. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Nonalcoholic steatosis (fatty liver) is a major cause of liver dysfunction that is associated with insulin resistance and metabolic syndrome. The cJun NH 2 -terminal kinase 1 (JNK1) signaling pathway is implicated in the pathogenesis of hepatic steatosis and drugs that target JNK1 may be useful for
## Abstract Population‐based case‐control design has become one of the most popular approaches for conducting genome‐wide association scans for rare diseases like cancer. In this article, we propose a novel method for improving the power of the widely used single‐single‐nucleotide polymorphism (SNP